Vaccine Safety Board Chides AstraZeneca for Using ‘Outdated’ Data in Press Release About its COVID-19 Shot

In an unusual move, on March 23 the U.S. National Institute of Allergy and Infectious Diseases (NIAID) issued a strongly worded statement asking AstraZeneca to “ensure the most accurate, up-to-date efficacy data be made public as quickly as possible.” On March 22, AstraZeneca released the results of its long-awaited U.S. trial of its COVID-19 vaccine, … Read more

AstraZeneca May Have Used Outdated Information in Its Vaccine Trial, U.S. Health Officials Say

WASHINGTON — Results from a U.S. trial of AstraZeneca’s COVID-19 vaccine may have used “outdated information,” U.S. federal health officials said early Tuesday. The Data and Safety Monitoring Board said in a statement that it was concerned that AstraZeneca may have provided an incomplete view of the efficacy data. AstraZeneca reported Monday that its COVID-19 … Read more